SCHEMBL21796218

SCHEMBL21796218

CCS(=O)(=O)c1ccc(NC(=O)NC)nc1-c1nc2cc(C(F)(F)F)nnc2n1C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDR1 Q08345 3/20 0.33
▸ RORC P51449 3/20 0.31
▸ ACVR1 Q04771 4/20 0.31
▸ CLK4 Q9HAZ1 4/20 0.31
▸ MST1R Q04912 2/20 0.31
▸ CDK8 P49336 2/20 0.31
▸ GSK3A P49840 2/20 0.31
▸ GSK3B P49841 2/20 0.31
▸ TYRO3 Q06418 1/20 0.31
▸ KIT P10721 1/20 0.31
▸ PRKD3 O94806 1/20 0.30
▸ PRKCG P05129 1/20 0.30
▸ CDK1 P06493 1/20 0.30
▸ CDK2 P24941 1/20 0.30
▸ FLT4 P35916 1/20 0.30
▸ FLT3 P36888 1/20 0.30
▸ FRK P42685 1/20 0.30
▸ CSNK2A1 P68400 1/20 0.30
▸ CDK5 Q00535 1/20 0.30
▸ STK3 Q13188 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21796216 0.93 RORC (0.31) RORC
SCHEMBL29774752 0.93 RORC (0.31) RORC
SCHEMBL21999932 0.92 PIK3CA (0.37) DDR1AURKB
SCHEMBL21999358 0.91 PIK3CD (0.32) ACVR1CLK4MST1RCDK8PRKD3
SCHEMBL21998973 0.89 DDR1 (0.33) DDR1RORC
SCHEMBL22280577 0.86 RORC (0.35) DDR1RORCACVR1CLK4MST1R
SCHEMBL18498639 0.85 DDR1 (0.39) DDR1RORC
SCHEMBL21999354 0.85 PIK3CA (0.34) AURKB
SCHEMBL20042377 0.85 RORC (0.34) DDR1RORCACVR1CLK4MST1R
SCHEMBL30051769 0.85 RORC (0.34) DDR1RORCACVR1CLK4MST1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11505553-B2 2-(Het)aryl-substituted fused heterocycle derivatives as pesticides BAYER AKTIENGESELLSCHAFT (DE) 2022-11-22 — — US disclosed
US-11089783-B2 2-(het)aryl-substituted fused heterocycle derivatives as pesticides BAYER AKTIENGESELLSCHAFT (DE) 2021-08-17 — — US disclosed
EP-3619212-B1 2- (HET) ARYL-SUBSTITUTED CONDENSED HETEROCYCLE DERIVATIVES AS PESTICIDES BAYER AG (DE) 2021-05-26 — — EP disclosed
US-20200146293-A1 2-(HET)ARYL-SUBSTITUTED FUSED HETEROCYCLE DERIVATIVES AS PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2020-05-14 — — US disclosed
US-20200148686-A1 2-(HET)ARYL-SUBSTITUTED FUSED HETEROCYCLE DERIVATIVES AS PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2020-05-14 — — US disclosed
US-20200148686-A1 2-(HET)ARYL-SUBSTITUTED FUSED HETEROCYCLE DERIVATIVES AS PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2020-05-14 — — US disclosed
EP-3619212-A1 2-(HET)ARYL-SUBSTITUTED CONDENSED BICYCLIC HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS Bayer AG (DE) 2020-03-11 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200148686-A1 2-(HET)ARYL-SUBSTITUTED FUSED HETEROCYCLE DERIVATIVES AS PESTICIDES HRH4, AHR, DDT DDR1 2001/4885RORC 1658/4885ACVR1 525/4885
US-11089783-B2 2-(het)aryl-substituted fused heterocycle derivatives as pesticides AHR, DDT, CYP8B1 DDR1 2201/4885RORC 3521/4885ACVR1 668/4885
US-20200146293-A1 2-(HET)ARYL-SUBSTITUTED FUSED HETEROCYCLE DERIVATIVES AS PESTICIDES AHR, DDT, CYP8B1 DDR1 2201/4885RORC 3521/4885ACVR1 668/4885
US-11505553-B2 2-(Het)aryl-substituted fused heterocycle derivatives as pesticides HRH4, AHR, DDT DDR1 2001/4885RORC 1658/4885ACVR1 525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback